Tu banner alternativo

Pamicogrel

In today's world, Pamicogrel has become a topic of great relevance and interest to many people. It has become a point of discussion and debate in different areas, whether on a personal, professional or academic level. The impact of Pamicogrel has been felt in society in a significant way, generating conflicting opinions and triggering research and studies that seek to delve deeper into its implications. Since its inception, Pamicogrel has captured the attention of millions of people around the world, sparking genuine interest and motivating professionals and experts to address its various facets and dimensions. In this context, it is important to fully explore the role of Pamicogrel today and its influence on daily life, as well as reflect on its projection in the future.

Tu banner alternativo
Pamicogrel
Names
Preferred IUPAC name
Ethyl {2--1H-pyrrol-1-yl}acetate
Other names
KB 3022, Paminate
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C25H24N2O4S/c1-4-31-22(28)16-27-15-5-6-21(27)25-26-23(17-7-11-19(29-2)12-8-17)24(32-25)18-9-13-20(30-3)14-10-18/h5-15H,4,16H2,1-3H3
    Key: ISCHOARKJADAKJ-UHFFFAOYSA-N
  • InChI=1/C25H24N2O4S/c1-4-31-22(28)16-27-15-5-6-21(27)25-26-23(17-7-11-19(29-2)12-8-17)24(32-25)18-9-13-20(30-3)14-10-18/h5-15H,4,16H2,1-3H3
    Key: ISCHOARKJADAKJ-UHFFFAOYAC
  • CCOC(=O)CN1C=CC=C1C2=NC(=C(S2)C3=CC=C(C=C3)OC)C4=CC=C(C=C4)OC
Properties
C25H24N2O4S
Molar mass 448.54 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa).

Pamicogrel is a cyclooxygenase inhibitor that was under development for its anti-platelet-aggregation effects.[1][2]

References

  1. ^ Light P (September 1999). "Pamicogrel (Kanebo)". IDrugs. 2 (9): 938–42. PMID 16121308.
  2. ^ "Pamicogrel inhibits platelet aggregation". Inpharma Weekly. 1272 (1): 11. January 2001. doi:10.2165/00128413-200112720-00021. S2CID 195132149.
  • The dictionary definition of pamicogrel at Wiktionary